NYSE$AMWL

American Well Corp · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported financial results for the third quarter of 2024.

Amwell reported a total revenue of $61.0 million for Q3 2024. The company is focused on aligning its cost structure and building its growth organization to deliver high quality, higher margin revenue. They are also underway in delivering the successful deployment of the Defense Heath Agency’s Digital First Initiative for the Military Health System.

  • Total Revenue was $61.0 million.
  • Subscription revenue was $26.2 million.
  • Amwell Medical Group visit revenue was $27.5 million.
  • Gross margin was 37%.

Headline financials

Total Revenue

$61M

Previous: $61.9M-1.4%
EPS

-$2.87

Previous: -$4.20+31.7%
Total Visits

1.4M

Previous: 1.4M+0.0%
Gross Margin

37.0%

Previous: 35.0%+5.7%
Capital Expenditures

-$116K

Previous: -$96K-20.8%
Free Cash Flow

-$43.6M

Previous: -$137M+68.1%
Net Income

-$43.5M

Previous: -$136M+68.1%
Operating Income

-$47.4M

Previous: -$143M+67.0%
Gross Profit

-$47.4M

Previous: -$143M+67.0%
R&D Expense

$19.8M

Previous: $27.7M-28.6%
Stock-Based Comp

$10.6M

Previous: $16.9M-37.2%

Revenue & EPS history

American Well · Revenue · Quarterly

$61M

Q3 2024-1.4%vs Q3 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

American Well · $28.4M total across 1 segment · Q3 2023

  • Subscription Revenue
    $28.4M-11.0%

Forward guidance

The company revised its guidance for revenue and AMG visits, while improving its guidance for 2024 Adjusted EBITDA.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+1.4%

Avg return

Earnings day

+2.1%

Avg return

5 days after

-2.2%

Avg return

30 days after

41%

9 / 22 earnings

Positive

+33.8%

Q2 2024

Best reaction

-20.9%

Q1 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.0%+27.2%+34.0%
Q4 2025+24.7%+34.9%+29.8%
Q3 2025-9.5%-20.0%-20.6%
Q1 2025+19.7%+9.5%+8.9%
Q4 2024-5.0%-3.6%-35.5%
Q3 2024-5.0%-5.4%-0.7%
Q2 2024+33.8%+13.9%-1.1%
Q1 2024+2.0%+11.4%-16.3%
Q4 2023+23.6%+20.8%-16.0%
Q3 2023+14.5%+4.3%+11.1%
Q2 2023-8.3%-13.9%-35.2%
Q1 2023-3.9%-2.9%+17.9%
Q4 2022-13.1%-19.2%-37.3%
Q3 2022-2.2%+14.9%-8.3%
Q2 2022+9.2%+6.8%-4.8%
Q1 2022-10.8%+8.8%+37.6%
Q4 2021+7.2%+1.0%-8.0%
Q3 2021-7.4%-3.7%-29.7%
Q2 2021+0.7%-1.7%+0.8%
Q1 2021-20.9%-5.7%+9.5%
Q4 2020-4.1%-10.8%-1.5%
Q3 2020-11.9%-19.8%+17.1%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro